Previous Article | Next Article ![]()
Infection and Immunity, April 2005, p. 1964-1970, Vol. 73, No. 4
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.4.1964-1970.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
J. L. Edwards,
,
J. Shao,
C. Rabinak,
D. Entz, and
M. A. Apicella*
Department of Microbiology, University of Iowa, Iowa City, Iowa
Received 30 September 2004/ Returned for modification 10 November 2004/ Accepted 30 November 2004
|
|
|---|
|
|
|---|
Our interest in the capability of N. gonorrhoeae to form a biofilm came about by observations made in our laboratory during 4- and 8-day infections of primary human urethral and cervical epithelial cells (8, 12). Those studies showed that the gonococcus was forming microcolonies on these surfaces, and eventually these transitioned into structures that resembled bacterial biofilms.
The purpose of this study was twofold. The first objective was to verify that N. gonorrhoeae can produce a biofilm both in biofilm chambers and over primary human genital tract epithelial cells in culture. The second objective was to gain information about the structure of the gonococcal biofilm. To accomplish this, we established gonococcal infections in continuous-flow chambers and on primary human genital tract epithelial cells. Light and electron microscopic analyses indicated that the gonococcus could form a biofilm on these surfaces and that the ultrastructure resembled that previously seen with other bacteria, with the exception that the biofilm was interlaced with what appeared to be membranous structures surrounding the organisms. Lectin and antibody analyses indicated that the biofilm sugars were similar to those that were expressed as terminal saccharides of gonococcal lipooligosaccharide (LOS).
|
|
|---|
Biofilm growth in a continuous-flow chamber. Gonococcal strains were grown in a continuous-flow chamber identical to that described by Davies et al. (5). RPMI 1640 medium (Gibco, Grand Island, N.Y.) containing 100 µM sodium pyruvate (Gibco), 20 ml of hypoxanthine (370 µM) and uracil (450 µM) per liter, 100 µM sodium nitrite, and 1% IsoVitaleX was prepared. In some experiments, 20 µM CMP-N-acetylneuraminic acid (CMP-Neu5Ac) was added to the medium. This solution was diluted 1:10 with sterile phosphate-buffered saline (PBS) and was used in the continuous-flow experiments. To inoculate the chamber, 1 ml of N. gonorrhoeae culture, grown to a density of 108 organisms/ml, was placed in the chamber and left for 1 h. The flow was then started at 150 µl/min. The biofilm was formed in a 37°C environmental incubator and continuously perfused over the duration of the experiment. At the end of that time period, the effluent was cultured to assure that the culture purity was maintained. Digital biofilm images were then collected.
Laser scanning confocal microscopy of continuous-flow chambers and cultured epithelial cells. Confocal images of biofilms in continuous-flow chambers and on primary human cervical epithelial cells in culture were obtained with a Bio-Rad MRC-1024 scanning confocal microscope as previously described (8). The chambers were viewed in situ under the confocal microscope. Cervical epithelial cells were grown on collagen-coated glass coverslips in a 24-well plate. Infections were performed in the chambers, and at various time points the coverslips were removed from the chambers and viewed with the confocal microscope after appropriate staining.
Viability staining of bacteria from continuous-flow chamber biofilms. To evaluate the viability of bacteria present within the biofilm matrix, N. gonorrhoeae 1291 was grown in a flow chamber as described above. After 4 days, the flow chamber was carefully disconnected. The Live/Dead BacLight bacterial viability kit (Molecular Probes, Eugene, Oreg.) was used to visualize live and dead bacteria within the biofilm. Briefly, SYTO 9 (component A) and propidium iodide (component B) were mixed at a 1:1 ratio. Three microliters of the viability stain was added to 1 ml of PBS. Medium in the chamber was aseptically replaced with the stain-PBS mixture. The chamber was incubated for 15 min at 37°C. One milliliter of sterile PBS was then added to the chamber to flush away excess stain. Biofilm bacteria within the chamber were immediately visualized with a Zeiss 510 laser scanning confocal microscope at a magnification of x10. The resulting images were compiled as cross-sections of a z series.
Fixation of biofilm samples for microscopy. All samples used for microscopy were grown in biofilm chambers in RPMI 1640 medium as described above. In all experiments other than the live/dead studies, a 1-ml mixture of 4% paraformaldehyde and 5% dimethyl sulfoxide was infused into the chamber at the end of the growth period and allowed to fix overnight. Samples were then embedded in situ in OCT resin (Sakura Finetek USA, Inc., Torrance, Calif.) on the coverslip surface upon which they were formed. After hardening, the coverslip was removed by freezing the sample in liquid nitrogen and shattering the glass, leaving the biofilm within the OCT resin. The biofilm was then cut into 1-µm-thick sections. N. gonorrhoeae strain 1291 was used for microscopic analyses unless otherwise noted.
Microscopy. OCT cryosections were incubated with hematoxylin and eosin stains to visualize the biofilm matrix. Images were viewed with an Olympus light microscope.
Biofilm samples from continuous-flow chambers were prepared for transmission electron microscopy (TEM) by using perfluorocarbon methods to minimize the extraction of water (22). Samples were embedded in Epon resin, sectioned, and viewed on an H-7000 instrument (Hitachi, Mountain View, Calif.) at a 75-kV accelerating voltage as previously described (12).
Biofilms grown on primary human cervical epithelial cells were processed for scanning electron microscopy (SEM) and viewed with a Hitachi S-4000 scanning electron microscope (8). Briefly, coverslips were fixed in a 2% osmium tetroxide-perfluorocarbon solution for 2 h, dehydrated with three 100% ethanol washes, and dried with hexamethyldisilazane (22) to preserve biofilm formation. Processed coverslips were then mounted onto stubs with colloidal silver and were sputter coated with gold palladium.
Biofilm samples grown in the presence of CMP-Neu5Ac were cultured (with gentle agitation) on glass coverslips, fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2), and rinsed in double-distilled H2O immediately before plunge-freezing in liquid nitrogen. Frozen specimens were introduced into an Emitech K1250 cryogenic system preparation chamber for radiant heat surface etching (a tungsten filament was heated by 20 A of current for 2 min). The uncoated samples were then introduced into and imaged with a Hitachi S-4000 cold cathode field emission scanning electron microscope (C-FESEM) (9, 21) All of the microscopes used in these studies are located at the University of Iowa Central Microscopy Research Facility (Iowa City).
Lectin analysis of biofilms. The OCT resin sections were studied by fluorescence microscopy with the fluorescein-conjugated lectins Maackia amurensis, Sambucus nigra, succinylated wheat germ, soybean agglutinin, and Amaryllis (all from EY Laboratories, San Mateo, Calif.) as previously described (10).
Antibody analysis of biofilms. OCT embedded sections were incubated with monoclonal antibodies (MAbs) 6B4 (murine immunoglobulin M [IgM]) and 2C3 (murine IgG). Anti-murine IgM-fluorescein isothiocyanate and anti-IgG-tetramethyl rhodamine isocyanate were used as secondary antibodies. Images of the samples were taken with the Bio-Rad MRC-1024 laser scanning confocal viewing system.
Gonococcal biofilm formation on primary human cervical epithelial cells. Surgical biopsies derived from the ecto- and the endocervix that were used to seed primary cervical epithelial cell systems were procured and maintained as described previously (5) in defined keratinocyte serum-free medium (Life Technologies, Rockville, Md.). Primary cervical epithelial cells were grown on coverslips as previously described by Edwards et al. (8). Once the cells were confluent, N. gonorrhoeae was added to the cell monolayer at a multiplicity of infection of 100. Infected cell layers were then incubated in a 37°C incubator with 5% CO2 for 4 or 8 days. Samples were then prepared for SEM. In another set of experiments, samples were infected with N. gonorrhoeae 1291[pGFP], fixed, and then stained with ethidium bromide. These samples were viewed with the Bio-Rad MRC-1024 laser scanning confocal viewing system.
|
|
|---|
![]() View larger version (122K): [in a new window] |
FIG. 1. Panel A shows a typical 4-day biofilm formed in the continuous-flow chamber by N. gonorrhoeae, and panel B shows the results of confocal analysis of a vertical reconstruction of a z series using live/dead staining of the biofilm. The majority of the organisms nearest the stream of flow are viable. Panels C and E show confocal analysis of strain 1291[pGFP] 4-day biofilm produced in defined medium in the presence of 10 µM sodium nitrite. The bars in these panels indicate 20 µm. Panel C shows a horizontal three-dimensional reconstruction of 60 images at 1-µm intervals (a stacked z series), and panel E shows the vertical view of the same stacked z series. Panels D and F show confocal analysis of strain 1291[pGFP] 4-day biofilm produced in defined medium in the absence of sodium nitrite. Panel D shows the stacked z series, and panel F shows the vertical view of the same stacked z series. (C to F) Bar, 20 µm.
|
![]() View larger version (167K): [in a new window] |
FIG. 2. Panel A shows a hematoxylin- and eosin-stained section of gonococcal strain 1291 4-day biofilm embedded in OCT and sectioned on a cryomicrotome. This panel shows organisms (dark blue) surrounded by a staining pink matrix. Panels B, C, and D show C-FESEM images of a 3-day biofilm at different magnifications. Panel B, taken at a magnification of x1,000, shows a broad view of the surface. Arrows point to an overlying membrane covering the biofilm. Panel C (magnification, x10,000) shows evidence of organisms embedded within membranous structures that appear to contain a matrix. Panel D (magnification, x20,000) demonstrates typical membranous structures seen crossing the biofilm.
|
![]() View larger version (182K): [in a new window] |
FIG. 3. Transmission electron micrographs of perfluorocarbon-fixed 3-day biofilm embedded in Epon resin. Panel A shows sections from the surface of the biofilm closest to the glass coverslip. Organisms can be seen contained within membranes. Panel B shows sections from the middle portion of the biofilm, showing organisms, membranes (arrows), and residual matrix. Panel C shows the top of the biofilm covered with membranes (dotted arrow). Panel D shows a immunoelectron micrographic study of a 3-day infection of primary human urethral epithelial cells (UEC). The section was incubated with MAb 6B4 as the primary antibody and with a goat anti-murine IgM gold conjugate as the secondary antibody. Membranous structures could be found over the epithelial cell surface surrounded by organisms. These membranes were covered with colloidal gold particles.
|
2-6Gal), M. amurensis (primary specificity, Neu5Ac
3-6Gal), Amaryllis (primary specificity, mannose), and soybean agglutinin (primary specificity, ß-linked N-acetylgalactosamine; secondary specificity, galactose). The only lectin that bound to the biofilm was soybean agglutinin. This suggested that the terminal sugar on the biofilm matrix when grown in the absence of CMP-Neu5Ac was either a ß-linked N-acetylgalactosamine or a galactose. To test whether Neu5Ac is incorporated into the biofilm, CMP-Neu5Ac (10 µM) was added to the growth medium. Lectin analysis demonstrated that soybean agglutinin failed to bind to the biofilm formed in the presence of CMP-Neu5Ac and that binding was restored after neuraminidase treatment of the biofilm (Fig. 5). M. amurensis lectin bound to the sialylated biofilm, and this binding was eliminated by treatment with neuraminidase. These studies indicated that NeuAc could be incorporated into the biofilm if the substrate CMP-Neu5Ac was available.
![]() View larger version (126K): [in a new window] |
FIG. 4. Lectin staining of a 4-day gonococcal strain 1291 biofilm. The biofilm was cyropreserved, embedded in OCT, and cyrosectioned. All of the lectins are conjugated to fluorescein. Panel A shows unstained biofilm. The remaining panels were stained with S. nigra (B), succinylated wheat germ (C), M. amurensis (D), soybean agglutinin (E), and Amaryllis (F). These studies suggest that the terminal sugar in the biofilm matrix is either a ß-linked-N-acetylgalactosamine or a galactose.
|
![]() View larger version (113K): [in a new window] |
FIG. 5. Lectin staining of an N. gonorrhoeae 1291 3-day biofilm grown in the presence of CMP-Neu5Ac. Panel A shows staining by M. amurensis before treatment with 0.05 U of neuraminidase/ml, and panel B shows a lack of binding after treatment with neuraminidase. Panel C shows a lack of binding of soybean agglutinin lectin before treatment with neuraminidase, and panel D shows restoration of binding after neuramindase treatment. This study indicates that structures within the biofilm can be sialylated in the presence of CMP-Neu5Ac.
|
![]() View larger version (64K): [in a new window] |
FIG. 6. Confocal microscopy of cyrosectioned 4-day gonococcal strain 1291 biofilm incubated with MAb 2C3 (red channel, panel A) and MAb 6B4 (green channel, panel B). MAb 2C3 is specific for an H.8 protein of pathogenic Neisseria spp., and MAb 6B4 is specific for the Galß1-4GlcNAc epitope. Panel C shows the merged image. The solid arrows designate the organisms in the biofilm in which MAbs 6B4 and 2C3 colocalize. The dotted arrows designate the regions of the biofilm binding MAb 6B4 and not colocalizing with strain 1291.
|
![]() View larger version (115K): [in a new window] |
FIG. 7. Tilted stacked z series of a confocal analysis of N. gonorrhoeae strain 1291 infected for 4 days over primary human cervical epithelial cells. The tissue culture medium was changed daily. The biofilm rises 20 to 30 µm above the cell layer. This tilted image of the 1291-infected sample demonstrates the topography of the biofilm over the epithelial cell surface at 4 days.
|
![]() View larger version (224K): [in a new window] |
FIG. 8. SEM of uninfected cervical cells (panel A) and of a 4-day infection of primary human cervical epithelial cells with strain 1291 (panels B and C). Panel D shows the results of an 8-day infection. The dotted arrow in panel B designates the cervical epithelial cell surface. The retracted matrix can be seen covering the top of the structure (solid arrow, panel B). The epithelial cell surface can also be seen (dotted arrow). Panel C shows a high-magnification (x25,000) view of the matrix covering the organisms (arrow). Panel D shows almost the entire epithelial cell surface covered by a biofilm at 8 days.
|
|
|
|---|
These studies have utilized several microscopic approaches to elucidate the structure of the biofilm produced by N. gonorrhoeae. Cryosections viewed by light microscopy indicated that organisms were surrounded by a matrix (Fig. 2A). Cryofield emission scanning electron microscopy and TEM have shown that this biofilm consists of membranous structures that appeared to be surrounding gonococci that may also be encased in a matrix. Binding studies with lectins and monoclonal antibody 6B4 showed that LOS-like structures predominate on the biofilm and that these structures could be identified separated from organisms within the biofilm (Fig. 3B and 6). These membranous extensions are interesting. They can reach 10 to 15 µm in length (Fig. 3A and B). We presume that they are derived from the bacterial outer membrane, which is shed from the gonococcus in the form of blebs. Our studies have shown that human primary genital tract epithelial cells can serve as surfaces for gonococcal biofilm formation with minimal, if any, effect on cell viability. This may reflect the ability of the gonococcus to induce antiapoptotic factors in these cells (2, 3).
Immunoelectron microscopy experiments with primary urethral epithelial cells show membrane structures resembling those seen in Fig. 3A. These structures stained heavily with monoclonal antibody 6B4. It is interesting to speculate that these membranous structures are derived in large part from the fusions of blebs shed by the gonococcus and the meningococcus during growth (6). These may encase the gonococci within sac-like structures into which a matrix is released. A recent study of biofilms produced by 39 Neisseria meningitidis strains showed that 30% of the carriage isolates and 12.5% of the invasive disease isolates formed biofilms in microtiter wells (25). Generally, the more hydrophobic the surface of the organism, the more likely it was to form a biofilm, and encapsulation inhibited biofilm formation. These studies support the concept that hydrophobic interactions of surfaces with pathogenic Neisseria spp. enhance their ability to form biofilms. The present study lends support to the theory that the membranous bacterially derived structures may facilitate biofilm formation.
A number of previous studies have demonstrated that gonococci can persist in an asymptomatic state in the female genital tract (13). In addition, antibiotic resistance to a broad range of agents has become a major concern with the management of gonococcal infections (24). The ability of this organism to form a biofilm on human cells, particularly in the female genital tract, may be a factor in both of these consequences of gonococcal infection. Future studies will be directed at studying the nature of the biofilm matrix and the role of biofilms during infection of cervical epithelial cells.
We acknowledge the staff of the Central Microscopy Research Facility at the University of Iowa.
L.L.G. and J.L.E. contributed equally to the work described in this paper. ![]()
Present address: Columbus Children's Research Institute, Columbus, OH 43205. ![]()
|
|
|---|
B in human urethral epithelium and increases the expression of host antiapoptotic factors. Infect. Immun. 72:6408-6417.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»